We are live on ! Find out more
MAM

Martingale Asset Management Portfolio holdings

AUM $3.99B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
+3.06%
1 Year Est. Return
+22.65%
3 Year Est. Return
+77.2%
5 Year Est. Return
+114.11%
10 Year Est. Return
+351.19%
AUM
$3.93B
AUM Growth
-$42.4M
Cap. Flow
-$91.1M
Cap. Flow %
-2.32%
Top 10 Hldgs %
12.14%
Holding
853
New
97
Increased
289
Reduced
356
Closed
83

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$18.2M
2
VLO icon
Valero Energy
VLO
+$10M
3
INCY icon
Incyte
INCY
+$9.41M
4
AMP icon
Ameriprise Financial
AMP
+$8.9M
5
DIS icon
Walt Disney
DIS
+$8.47M

Sector Composition

Rank Sector Weight
1 Financials 18.99%
2 Technology 17.12%
3 Healthcare 13.14%
4 Industrials 11.76%
5 Consumer Staples 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUE icon
751
Monte Rosa Therapeutics
GLUE
$1.33B
$195K ﹤0.01%
+12,413
New +$167K
CHCT
752
Community Healthcare Trust
CHCT
$446M
$166K ﹤0.01%
+10,106
New +$151K
MCHB
753
Mechanics Bancorp
MCHB
$3.72B
$161K ﹤0.01%
+10,974
New +$153K
NEXN
754
Nexxen International
NEXN
$610M
$160K ﹤0.01%
24,486
-40,387
-62% -$300K
CRD.A icon
755
Crawford & Co Class A
CRD.A
$625M
$157K ﹤0.01%
13,994
JANX icon
756
Janux Therapeutics
JANX
$982M
$155K ﹤0.01%
+11,240
New +$264K
PANL icon
757
Pangaea Logistics
PANL
$487M
$150K ﹤0.01%
+21,745
New +$132K
CCRN
758
DELISTED
Cross Country Healthcare
CCRN
$132K ﹤0.01%
16,315
-11,171
-41% -$122K
EGAN icon
759
eGain
EGAN
$202M
$123K ﹤0.01%
11,954
-14,126
-54% -$169K
TDOC icon
760
Teladoc Health
TDOC
$1.21B
$116K ﹤0.01%
+16,532
New +$129K
SXC icon
761
SunCoke Energy
SXC
$815M
$110K ﹤0.01%
15,288
-6,500
-30% -$47.8K
RPAY icon
762
Repay Holdings
RPAY
$330M
$90.2K ﹤0.01%
24,700
+7,400
+43% +$29.7K
HPK icon
763
HighPeak Energy
HPK
$867M
$89.2K ﹤0.01%
18,828
-8,906
-32% -$53.5K
FDMT icon
764
4D Molecular Therapeutics
FDMT
$552M
$88.3K ﹤0.01%
11,775
+1,303
+12% +$13.2K
NAGE
765
Niagen Bioscience
NAGE
$241M
$84.9K ﹤0.01%
+13,351
New +$92.9K
PTON icon
766
Peloton Interactive
PTON
$2.38B
$74.5K ﹤0.01%
+12,097
New +$85.2K
BMBL icon
767
Bumble
BMBL
$372M
$71K ﹤0.01%
19,900
-4,700
-19% -$20.8K
SLDB icon
768
Solid Biosciences
SLDB
$857M
$59.6K ﹤0.01%
10,574
+346
+3% +$1.88K
ALT icon
769
Altimmune
ALT
$585M
$51.8K ﹤0.01%
+14,355
New +$62.6K
PRME icon
770
Prime Medicine
PRME
$533M
$51.4K ﹤0.01%
+14,808
New +$65.9K
ACMR icon
771
ACM Research
ACMR
$5.46B
-11,242
Closed -$440K
AGX icon
772
Argan
AGX
$8.28B
-3,202
Closed -$865K
AKRO
773
DELISTED
Akero Therapeutics
AKRO
-6,915
Closed -$328K
ARW icon
774
Arrow Electronics
ARW
$11.4B
-25,981
Closed -$3.14M
CVSA
775
Covista Inc
CVSA
$4.23B
-1,927
Closed -$298K

Similar funds

Martingale Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Martingale Asset Management held 853 positions worth $3.93B, down 1.1% from $3.98B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Martingale Asset Management's Q4 2025 filing shows 97 new, 289 increased, 356 reduced and 83 closed positions. Its largest new stake was Smithfield Foods: 343,963 shares worth $7.68M. The largest sale was Curtiss-Wright, an estimated $24.8M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Martingale Asset Management's largest Q4 2025 buy was Smithfield Foods: 343,963 shares worth $7.68M.
  • Martingale Asset Management added most to TJX Companies in Q4 2025, an estimated $18.2M increase.
  • Martingale Asset Management's biggest Q4 2025 reduction was Curtiss-Wright, cutting an estimated $24.8M.
  • Martingale Asset Management fully exited Electronic Arts in Q4 2025, selling an estimated $23.4M.
  • Martingale Asset Management's ten largest holdings make up 12% of its $3.93B portfolio in Q4 2025.
  • Martingale Asset Management opened 97 new positions and closed 83 in Q4 2025.
  • Martingale Asset Management's portfolio value fell 1.1% quarter-over-quarter to $3.93B.

Based on Martingale Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.